Clinical Trial Update: A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of luspatercept in adults with non transfusion dependent beta-thalassemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Thalassemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Celgene | Conditions: Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2021-11-18